After-Hours Movers 10/26: (LRN) (VRNS) (AIG) Higher; (CATB) (DXCM) (CHGG) Lower (more...)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
Mirati Therapeutics (MRTX) Prices 4.33M Share Common Offering at $202/Sh
October 28, 2020 5:57 AM EDTMirati Therapeutics, Inc. (NASDAQ: MRTX) today announced the pricing of an underwritten public offering of 4,335,397 shares of its common stock at a price to the public of $202.00 per share, which consists of 3,960,397 shares to be sold by Mirati and 375,000 shares to be sold by a selling stockholder. The aggregate gross proceeds to Mirati from this offering are expected to be approximately $800.0 million, before... More
Argus Reiterates Buy Rating on Twilio (TWLO) Following 3Q
October 27, 2020 7:22 AM EDTArgus analyst Jim Kelleher reiterated a Buy rating and $330.00 price target on Twilio (NYSE: TWLO) following the company's 3Q earnings report. Twilio reported 3Q20 revenue of $448 million. Above revised consensus forecast of $410million. TWLO reported non-GAAP profit of $0.04 per diluted share in 3Q20.... More
